Breast cancer is a heterogeneous disease with distinct molecular subtypes, including triple-negative breast cancer (TNBC), estrogen receptor-positive/progesterone receptor-positive (ER+/PR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-positive breast cancer (TPBC)53. This evidence concerns the gene ERBB2 and breast cancer.